Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: Expression, trafficking and possible role in pain

Molecular Pain

Volumn 10, Issue 1, 2014, Pages

  Shi, Tie Jun S ^a,b   Xiang, Qiong ^a,b   Zhang, Ming Dong ^a   Barde, Swapnali ^a   Kai Larsen, Ylva ^a   Fried, Kaj ^a   Josephson, Anna ^a   Glück, Laura ^c   Deyev, Sergey M ^d   Zvyagin, Andrei V ^e   Schulz, Stefan ^c   Hökfelt, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^e MACQUARIE UNIVERSITY   (Australia)

Author keywords

Axonal transport; Nerve injury; Neuropeptide; NPY receptor; Receptor internalization; Retrograde signaling

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPEPTIDE Y1 RECEPTOR; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 2A; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HINDLIMB; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNALIZATION; MALE; MIDDLE AGED; MOUSE; NERVE CELL; NERVE ENDING; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCIATIC NERVE; SPINAL CORD DORSAL HORN; SPINAL GANGLION; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FUNCTIONAL LATERALITY; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; GREEN FLUORESCENT PROTEINS; HUMANS; HYPERALGESIA; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; OCTREOTIDE; OLIGOPEPTIDES; PAIN THRESHOLD; PROTEIN TRANSPORT; RECEPTORS, SOMATOSTATIN; SCIATICA; SENSORY RECEPTOR CELLS; SOMATOSTATIN;

EID: 84893637715     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-10-12     Document Type: Article

References (131)

1. Epelbaum J. Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol 1986, 27:63-100. 10.1016/0301-0082(86)90012-2, 2874591.
2. Reisine T. Somatostatin. Cell Mol Neurobiol 1995, 15:597-614. 10.1007/BF02071127, 8719032.
3. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999, 20:157-198. 10.1006/frne.1999.0183, 10433861.
4. Siler TM, VandenBerg G, Yen SS, Brazeau P, Vale W, Guillemin R. Inhibition of growth hormone release in humans by somatostatin. J Clin Endocrinol Metab 1973, 37:632-634. 10.1210/jcem-37-4-632, 4742541.
5. Brownstein M, Arimura A, Sato H, Schally AV, Kizer JS. The regional distribution of somatostatin in the rat brain. Endocrinology 1975, 96:1456-1461. 10.1210/endo-96-6-1456, 1126315.
6. Hökfelt T, Efendic S, Hellerström C, Johansson O, Luft R, Arimura A. Cellular localization of somatostatin in endocrine-like cells and neurons in the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol Suppl (Copenh) 1975, 200:5-41.
7. Renaud LP, Martin JB, Brazeau P. Depressant action of TRH, LH-RH and somatostatin on activity of central neurones. Nature 1975, 255:233-235. 10.1038/255233a0, 806808.
8. Hökfelt T, Elde R, Johansson O, Luft R, Nilsson G, Arimura A. Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience 1976, 1:131-136. 10.1016/0306-4522(76)90008-7, 1004708.
9. Lawson SN. Neuropeptides in morphologically and functionally identified primary afferent neurons in dorsal root ganglia: substance P, CGRP and somatostatin. Prog Brain Res 1995, 104:161-173.
10. Kashiba H, Ueda Y, Senba E. Coexpression of preprotachykinin-A, alpha-calcitonin gene-related peptide, somatostatin, and neurotrophin receptor family messenger RNAs in rat dorsal root ganglion neurons. Neuroscience 1996, 70:179-189. 10.1016/0306-4522(95)00334-F, 8848123.
11. Ju G, Hökfelt T, Brodin E, Fahrenkrug J, Fischer JA, Frey P, Elde RP, Brown JC. Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells. Cell Tissue Res 1987, 247:417-431.
12. Dalsgaard CJ, Hökfelt T, Johansson O, Elde R. Somatostatin immunoreactive cell bodies in the dorsal horn and the parasympathetic intermediolateral nucleus of the rat spinal cord. Neurosci Lett 1981, 27:335-339. 10.1016/0304-3940(81)90453-5, 6120492.
13. Hunt SP, Kelly JS, Emson PC, Kimmel JR, Miller RJ, Wu JY. An immunohistochemical study of neuronal populations containing neuropeptides or gamma-aminobutyrate within the superficial layers of the rat dorsal horn. Neuroscience 1981, 6:1883-1898. 10.1016/0306-4522(81)90029-4, 6170908.
14. Proudlock F, Spike RC, Todd AJ. Immunocytochemical study of somatostatin, neurotensin, GABA, and glycine in rat spinal dorsal horn. J Comp Neurol 1993, 327:289-297. 10.1002/cne.903270210, 7678841.
15. Chapman V, Dickenson AH. The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord. Neuropeptides 1992, 23:147-152. 10.1016/0143-4179(92)90115-D, 1361670.
16. Murase K, Nedeljkov V, Randic M. The actions of neuropeptides on dorsal horn neurons in the rat spinal cord slice preparation: an intracellular study. Brain Res 1982, 234:170-176. 10.1016/0006-8993(82)90483-8, 6174183.
17. Randic M, Miletic V. Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli. Brain Res 1978, 152:196-202. 10.1016/0006-8993(78)90148-8, 679024.
18. Sandkuhler J, Fu QG, Helmchen C. Spinal somatostatin superfusion in vivo affects activity of cat nociceptive dorsal horn neurons: comparison with spinal morphine. Neuroscience 1990, 34:565-576. 10.1016/0306-4522(90)90165-Z, 1972267.
19. Yasaka T, Tiong SY, Hughes DI, Riddell JS, Todd AJ. Populations of inhibitory and excitatory interneurons in lamina II of the adult rat spinal dorsal horn revealed by a combined electrophysiological and anatomical approach. Pain 2010, 151:475-488. 10.1016/j.pain.2010.08.008, 3170912, 20817353.
20. Carlton SM, Du J, Zhou S, Coggeshall RE. Tonic control of peripheral cutaneous nociceptors by somatostatin receptors. J Neurosci 2001, 21:4042-4049.
21. Carlton SM, Du J, Davidson E, Zhou S, Coggeshall RE. Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors. Pain 2001, 90:233-244. 10.1016/S0304-3959(00)00407-3, 11207395.
22. Helyes Z, Szabo A, Nemeth J, Jakab B, Pinter E, Banvolgyi A, Kereskai L, Keri G, Szolcsanyi J. Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the rat. Arthritis Rheum 2004, 50:1677-1685. 10.1002/art.20184, 15146439.
23. Helyes Z, Than M, Oroszi G, Pinter E, Nemeth J, Keri G, Szolcsanyi J. Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat. Neurosci Lett 2000, 278:185-188. 10.1016/S0304-3940(99)00936-2, 10653024.
24. Imhof AK, Gluck L, Gajda M, Lupp A, Brauer R, Schaible HG, Schulz S. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. Arthritis and Rheumatism 2011, 63:2352-2362. 10.1002/art.30410, 21506098.
25. Maurer R, Gaehwiler BH, Buescher HH, Hill RC, Roemer D. Opiate antagonistic properties of an octapeptide somatostatin analog. Proc Natl Acad Sci U S A 1982, 79:4815-4817. 10.1073/pnas.79.15.4815, 346769, 6126877.
26. Pinter E, Helyes Z, Szolcsanyi J. Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 2006, 112:440-456. 10.1016/j.pharmthera.2006.04.010, 16764934.
27. Szolcsanyi J, Bolcskei K, Szabo A, Pinter E, Petho G, Elekes K, Borzsei R, Almasi R, Szuts T, Keri G, Helyes Z. Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia. Eur J Pharmacol 2004, 498:103-109. 10.1016/j.ejphar.2004.07.085, 15363982.
28. Szolcsanyi J, Pinter E, Helyes Z, Oroszi G, Nemeth J. Systemic anti-inflammatory effect induced by counter-irritation through a local release of somatostatin from nociceptors. Br J Pharmacol 1998, 125:916-922. 10.1038/sj.bjp.0702144, 1571027, 9831933.
29. Szolcsanyi J, Helyes Z, Oroszi G, Nemeth J, Pinter E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol 1998, 123:936-942. 10.1038/sj.bjp.0701685, 1565240, 9535023.
30. Helyes Z, Pinter E, Sandor K, Elekes K, Banvolgyi A, Keszthelyi D, Szoke E, Toth DM, Sandor Z, Kereskai L, Pozsgai G, Allen JP, Emson PC, Markovics A. Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice. Proc Natl Acad Sci USA 2009, 106:13088-13093. 10.1073/pnas.0900681106, 2722291, 19622729.
31. Sandor K, Elekes K, Szabo A, Pinter E, Engstrom M, Wurster S, Szolcsanyi J, Helyes Z. Analgesic effects of the somatostatin sst4 receptor selective agonist J-2156 in acute and chronic pain models. Eur J of Pharmacol 2006, 539:71-75.
32. Mollenholt P, Rawal N, Gordh T, Olsson Y. Intrathecal and epidural somatostatin for patients with cancer. Analgesic effects and postmortem neuropathologic investigations of spinal cord and nerve roots. Anesthesiology 1994, 81:534-542. 10.1097/00000542-199409000-00004, 7916546.
33. Penn RD, Paice JA, Kroin JS. Octreotide: a potent new non-opiate analgesic for intrathecal infusion. Pain 1992, 49:13-19. 10.1016/0304-3959(92)90182-B, 1594275.
34. Sicuteri F, Geppetti P, Marabini S, Lembeck F. Pain relief by somatostatin in attacks of cluster headache. Pain 1984, 18:359-365. 10.1016/0304-3959(84)90048-4, 6145138.
35. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PP, O'Carroll AM, Patel YC, Schonbrunn A, Taylor JE, Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 1995, 16:86-88. 10.1016/S0165-6147(00)88988-9, 7792934.
36. Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel SC, Patel YC. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 1999, 48:77-85. 10.2337/diabetes.48.1.77, 9892225.
37. Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W. Regulation and function of somatostatin receptors. J Neurochem 2004, 89:1057-1091. 10.1111/j.1471-4159.2004.02402.x, 15147500.
38. Reisine T, Bell GI. Molecular properties of somatostatin receptors. Neuroscience 1995, 67:777-790. 10.1016/0306-4522(95)00072-Q, 7675204.
39. Uhl GR, Tran V, Snyder SH, Martin JB. Somatostatin receptors: distribution in rat central nervous system and human frontal cortex. J Comp Neurol 1985, 240:288-304. 10.1002/cne.902400306, 2866202.
40. Holloway S, Feniuk W, Kidd EJ, Humphrey PP. A quantitative autoradiographical study on the distribution of somatostatin sst2 receptors in the rat central nervous system using [125I]-BIM-23027. Neuropharmacology 1996, 35:1109-1120. 10.1016/S0028-3908(96)00082-2, 9121614.
41. Maubert E, Slama A, Ciofi P, Viollet C, Tramu G, Dupouy JP, Epelbaum J. Developmental patterns of somatostatin-receptors and somatostatin-immunoreactivity during early neurogenesis in the rat. Neuroscience 1994, 62:317-325. 10.1016/0306-4522(94)90335-2, 7816210.
42. Schindler M, Holloway S, Hathway G, Woolf CJ, Humphrey PP, Emson PC. Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception. Brain Res 1998, 798:25-35. 10.1016/S0006-8993(98)00361-8, 9666064.
43. Schulz S, Schmidt H, Handel M, Schreff M, Hollt V. Differential distribution of alternatively spliced somatostatin receptor 2 isoforms (sst2A and sst2B) in rat spinal cord. Neurosci Lett 1998, 257:37-40. 10.1016/S0304-3940(98)00803-9, 9857960.
44. Schulz S, Schreff M, Schmidt H, Handel M, Przewlocki R, Hollt V. Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia. Eur J Neurosci 1998, 10:3700-3708. 10.1046/j.1460-9568.1998.00386.x, 9875349.
45. Bar KJ, Schurigt U, Scholze A, Segond Von Banchet G, Stopfel N, Brauer R, Halbhuber KJ, Schaible HG. The expression and localization of somatostatin receptors in dorsal root ganglion neurons of normal and monoarthritic rats. Neuroscience 2004, 127:197-206. 10.1016/j.neuroscience.2004.04.051, 15219682.
46. Senaris RM, Schindler M, Humphrey PP, Emson PC. Expression of somatostatin receptor 3 mRNA in the motorneurones of the rat spinal cord, and the sensory neurones of the spinal ganglia. Brain Res Mol Brain Res 1995, 29:185-190. 10.1016/0169-328X(94)00275-J, 7769996.
47. Gamboa-Esteves FO, McWilliam PN, Batten TF. Substance P (NK1) and somatostatin (sst2A) receptor immunoreactivity in NTS-projecting rat dorsal horn neurones activated by nociceptive afferent input. J Chem Neuroanat 2004, 27:251-266. 10.1016/j.jchemneu.2004.04.001, 15261332.
48. Ji GC, Zhou ST, Shapiro G, Reubi JC, Jurczyk S, Carlton SM. Analgesic activity of a non-peptide imidazolidinedione somatostatin agonist: in vitro and in vivo studies in rat. Pain 2006, 124:34-49. 10.1016/j.pain.2006.03.014, 16650579.
49. Pan HL, Wu ZZ, Zhou HY, Chen SR, Zhang HM, Li DP. Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther 2008, 117:141-161. 10.1016/j.pharmthera.2007.09.003, 2965406, 17959251.
50. Takeda M, Kadoi J, Takahashi M, Nasu M, Matsumoto S. Somatostatin inhibits the excitability of rat small-diameter trigeminal ganglion neurons that innervate nasal mucosa and project to the upper cervical dorsal horn via activation of somatostatin 2a receptor. Neuroscience 2007, 148:744-756. 10.1016/j.neuroscience.2007.06.048, 17706880.
51. Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87:149-158. 10.1016/S0304-3959(00)00276-1, 10924808.
52. Shields SD, Eckert WA, Basbaum AI. Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis. J Pain 2003, 4:465-470. 10.1067/S1526-5900(03)00781-8, 14622667.
53. Dubovy P, Svizenska I, Vega JA. Non-specific cholinesterase activity in mouse spinal ganglia. The usefulness of histochemical study and image analysis for simple characterization of neuron subclasses. Cell Mol Biol 1990, 36:23-40.
54. McMahon SB, Priestley JV. Nociceptor plasticity. The Neurobiology of Pain 2005, 35-64. Hunt SP, Koltzenburg M.
55. Malmberg AB, Chen C, Tonegawa S, Basbaum AI. Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 1997, 278:279-283. 10.1126/science.278.5336.279, 9323205.
56. Shi TJ, Li J, Dahlstrom A, Theodorsson E, Ceccatelli S, Decosterd I, Pedrazzini T, Hökfelt T. Deletion of the neuropeptide Y Y1 receptor affects pain sensitivity, neuropeptide transport and expression, and dorsal root ganglion neuron numbers. Neuroscience 2006, 140:293-304. 10.1016/j.neuroscience.2006.02.009, 16564642.
57. Lesche S, Lehmann D, Nagel F, Schmid HA, Schulz S. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. J Clin Endocrinol Metab 2009, 94:654-661. 10.1210/jc.2008-1919, 19001514.
58. Shimon I. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs. Endocrine 2003, 20:265-269. 10.1385/ENDO:20:3:265, 12721506.
59. Bass RT, Buckwalter BL, Patel BP, Pausch MH, Price LA, Strnad J, Hadcock JR. Identification and characterization of novel somatostatin antagonists. Mol Pharmacol 1996, 50:709-715.
60. Dal Monte M, Petrucci C, Cozzi A, Allen JP, Bagnoli P. Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina. Naunyn Schmiedebergs Arch Pharmacol 2003, 367:188-192. 10.1007/s00210-002-0662-7, 12595961.
61. Zhang X, Bao L, Xu ZQ, Kopp J, Arvidsson U, Elde R, Hökfelt T. Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons. Proc Natl Acad Sci U S A 1994, 91:11738-11742. 10.1073/pnas.91.24.11738, 45307, 7972133.
62. Zhang X, Tong YG, Bao L, Hökfelt T. The neuropeptide Y Y1 receptor is a somatic receptor on dorsal root ganglion neurons and a postsynaptic receptor on somatostatin dorsal horn neurons. Eur J Neurosci 1999, 11:2211-2225. 10.1046/j.1460-9568.1999.00638.x, 10383610.
63. Ji RR, Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009, 60:135-148. 10.1016/j.brainresrev.2008.12.011, 2666786, 19150373.
64. Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007, 3:33. 10.1186/1744-8069-3-33, 2186318, 17974036.
65. Saksena S, Theegala S, Bansal N, Gill RK, Tyagi S, Alrefai WA, Ramaswamy K, Dudeja PK. Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2009, 297:G878-G885. 10.1152/ajpgi.00283.2009, 2777453, 20501436.
66. Wang C, Xu H, Chen H, Li J, Zhang B, Tang C, Ghishan FK. Somatostatin stimulates intestinal NHE8 expression via p38 MAPK pathway. Am J Physiol Cell Physiol 2011, 300:C375-C382. 10.1152/ajpcell.00421.2010, 3043635, 21106692.
67. War SA, Kumar U. Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis. J Mol Signal 2012, 7:5. 10.1186/1750-2187-7-5, 3403965, 22651821.
68. Alderton F, Humphrey PP, Sellers LA. High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors. Mol Pharmacol 2001, 59:1119-1128.
69. Kim SJ, Chung WH, Rhim H, Eun SY, Jung SJ, Kim J. Postsynaptic action mechanism of somatostatin on the membrane excitability in spinal substantia gelatinosa neurons of juvenile rats. Neuroscience 2002, 114:1139-1148. 10.1016/S0306-4522(02)00245-2, 12379266.
70. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003, 23:4017-4022.
71. Obata K, Yamanaka H, Kobayashi K, Dai Y, Mizushima T, Katsura H, Fukuoka T, Tokunaga A, Noguchi K. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci 2004, 24:10211-10222. 10.1523/JNEUROSCI.3388-04.2004, 15537893.
72. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell 2009, 139:267-284. 10.1016/j.cell.2009.09.028, 2852643, 19837031.
73. Sandkuhler J. Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 2009, 89:707-758. 10.1152/physrev.00025.2008, 19342617.
74. Todd AJ. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 2010, 11:823-836. 10.1038/nrn2947, 3277941, 21068766.
75. Djouhri L, Lawson SN. Abeta-fiber nociceptive primary afferent neurons: a review of incidence and properties in relation to other afferent A-fiber neurons in mammals. Brain Res Brain Res Rev 2004, 46:131-145. 10.1016/j.brainresrev.2004.07.015, 15464202.
76. Taylor BK. Spinal inhibitory neurotransmission in neuropathic pain. Curr pain and headache reports 2009, 13:208-214.
77. Willis WD. Central Sensitization of spinothalamic tract cells is a spinal cord form of long-term potentiation. Prog Pain Res Manag 2004, 30:181-199.
78. Todd AJ, Spike RC, Polgar E. A quantitative study of neurons which express neurokinin-1 or somatostatin sst2a receptor in rat spinal dorsal horn. Neuroscience 1998, 85:459-473. 10.1016/S0306-4522(97)00669-6, 9622244.
79. Todd AJ, Hughes DI, Polgar E, Nagy GG, Mackie M, Ottersen OP, Maxwell DJ. The expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in neurochemically defined axonal populations in the rat spinal cord with emphasis on the dorsal horn. Eur J Neurosci 2003, 17:13-27. 10.1046/j.1460-9568.2003.02406.x, 12534965.
80. Schoenen J, Lotstra F, Vierendeels G, Reznik M, Vanderhaeghen JJ. Substance P, enkephalins, somatostatin, cholecystokinin, oxytocin, and vasopressin in human spinal cord. Neurology 1985, 35:881-890. 10.1212/WNL.35.6.881, 2582309.
81. Marti E, Gibson SJ, Polak JM, Facer P, Springall DR, Van Aswegen G, Aitchison M, Koltzenburg M. Ontogeny of peptide- and amine-containing neurones in motor, sensory, and autonomic regions of rat and human spinal cord, dorsal root ganglia, and rat skin. J Comp Neurol 1987, 266:332-359. 10.1002/cne.902660304, 2447134.
82. Charnay Y, Chayvialle JA, Pradayrol L, Bouvier R, Paulin C, Dubois PM. Ontogeny of somatostatin-like immunoreactivity in the human fetus and infant spinal cord. Brain Res 1987, 433:63-73.
83. Nagao M, Oka N, Kamo H, Akiguchi I, Kimura J. Differential localization of lectin binding sites and neuropeptides in human dorsal root ganglia. Histochemistry 1994, 102:279-286. 10.1007/BF00269164, 7531191.
84. Hofland LJ, Lamberts SW. The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr Rev 2003, 24:28-47. 10.1210/er.2000-0001, 12588807.
85. Jacobs S, Schulz S. Intracellular trafficking of somatostatin receptors. Mol Cell Endocrinol 2008, 286:58-62. 10.1016/j.mce.2007.10.005, 18045773.
86. Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003, 24:389-427. 10.1210/er.2002-0007, 12920149.
87. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hollt V, Schulz S. Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 2004, 279:21374-21382. 10.1074/jbc.M313522200, 15001578.
88. Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 2002, 146:707-716. 10.1530/eje.0.1460707, 11980628.
89. Schmid HA. Pasireotide (SOM230): development, mechanism of action and potential applications. Mol Cell Endocrinol 2008, 286:69-74. 10.1016/j.mce.2007.09.006, 17977644.
90. Csaba Z, Bernard V, Helboe L, Bluet-Pajot MT, Bloch B, Epelbaum J, Dournaud P. In vivo internalization of the somatostatin sst2A receptor in rat brain: evidence for translocation of cell-surface receptors into the endosomal recycling pathway. Mol Cell Neurosci 2001, 17:646-661. 10.1006/mcne.2000.0958, 11312601.
91. Csaba Z, Lelouvier B, Viollet C, El Ghouzzi V, Toyama K, Videau C, Bernard V, Dournaud P. Activated somatostatin type 2 receptors traffic in vivo in central neurons from dendrites to the trans Golgi before recycling. Traffic 2007, 8:820-834. 10.1111/j.1600-0854.2007.00580.x, 17521381.
92. Pfeiffer M, Koch T, Schroder H, Klutzny M, Kirscht S, Kreienkamp HJ, Hollt V, Schulz S. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 2001, 276:14027-14036.
93. Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, Schulz S. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 2002, 277:19762-19772. 10.1074/jbc.M110373200, 11896051.
94. Wang J, Cao DY, Guo Y, Ma SJ, Luo R, Pickar JG, Zhao Y. Octreotide inhibits capsaicin-induced activation of C and Adelta afferent fibres in rat hairy skin in vivo. Clin Exp Pharmacol Physiol 2011, 38:521-527. 10.1111/j.1440-1681.2011.05542.x, 21595740.
95. Carlton SM, Zhou S, Du J, Hargett GL, Ji G, Coggeshall RE. Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. Pain 2004, 110:616-627. 10.1016/j.pain.2004.04.042, 15288402.
96. Luo R, Guo Y, Cao DY, Pickar JG, Li L, Wang J, Zhao Y. Local effects of octreotide on glutamate-evoked activation of Adelta and C afferent fibers in rat hairy skin. Brain Res 2010, 1322:50-58.
97. Wang J, Guo Y, Cao DY, Luo R, Ma SJ, Wang HS, Pickar JG, Zhao Y. Tonic inhibition of somatostatin on C and Adelta afferent fibers in rat dorsal skin in vivo. Brain Res 2009, 1288:50-59.
98. Seybold VS, Hylden JL, Wilcox GL. Intrathecal substance P and somatostatin in rats: behaviors indicative of sensation. Peptides 1982, 3:49-54. 10.1016/0196-9781(82)90141-3, 6176976.
99. Wiesenfeld-Hallin Z. Intrathecal somatostatin modulates spinal sensory and reflex mechanisms: behavioral and electrophysiological studies in the rat. Neurosci Lett 1985, 62:69-74. 10.1016/0304-3940(85)90286-1, 2866475.
100. Wiesenfeld-Hallin Z. Substance P and somatostatin modulate spinal cord excitability via physiologically different sensory pathways. Brain Res 1986, 372:172-175. 10.1016/0006-8993(86)91473-3, 2423189.
101. Wiesenfeld-Hallin Z. Somatostatin and calcitonin gene-related peptide synergistically modulate spinal sensory and reflex mechanisms in the rat: behavioral and electrophysiological studies. Neurosci Lett 1986, 67:319-323. 10.1016/0304-3940(86)90329-0, 2874534.
102. Gaumann DM, Yaksh TL. Intrathecal somatostatin in rats: antinociception only in the presence of toxic effects. Anesthesiology 1988, 68:733-742. 10.1097/00000542-198805000-00011, 2897175.
103. Mollenholt P, Post C, Rawal N, Freedman J, Hökfelt T, Paulsson I. Antinociceptive and 'neurotoxic' actions of somatostatin in rat spinal cord after intrathecal administration. Pain 1988, 32:95-105. 10.1016/0304-3959(88)90028-0, 2893326.
104. Jiang N, Furue H, Katafuchi T, Yoshimura M. Somatostatin directly inhibits substantia gelatinosa neurons in adult rat spinal dorsal horn in vitro. Neurosci Res 2003, 47:97-107. 10.1016/S0168-0102(03)00183-4, 12941451.
105. Brumovsky P, Shi TS, Landry M, Villar MJ, Hökfelt T. Neuropeptide tyrosine and pain. Trends Pharmacol Sci 2007, 28:93-102. 10.1016/j.tips.2006.12.003, 17222466.
106. Smith PA, Moran TD, Abdulla F, Tumber KK, Taylor BK. Spinal mechanisms of NPY analgesia. Peptides 2007, 28:464-474. 10.1016/j.peptides.2006.09.029, 17194506.
107. Gibson SJ, Polak JM, Allen JM, Adrian TE, Kelly JS, Bloom SR. The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals. J Comp Neurol 1984, 227:78-91. 10.1002/cne.902270109, 6432858.
108. Gibbs JL, Flores CM, Hargreaves KM. Attenuation of capsaicin-evoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors. Pain 2006, 124:167-174. 10.1016/j.pain.2006.04.013, 16714086.
109. Hökfelt T, Brumovsky P, Shi T, Pedrazzini T, Villar M. NPY and pain as seen from the histochemical side. Peptides 2007, 28:365-372. 10.1016/j.peptides.2006.07.024, 17234301.
110. Taiwo OB, Taylor BK. Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors. Pain 2002, 96:353-363. 10.1016/S0304-3959(01)00481-X, 11973010.
111. Allen JP, Canty AJ, Schulz S, Humphrey PP, Emson PC, Young HM. Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice. J Comp Neurol 2002, 454:329-340. 10.1002/cne.10466, 12442323.
112. Stumm RK, Zhou C, Schulz S, Endres M, Kronenberg G, Allen JP, Tulipano G, Hollt V. Somatostatin receptor 2 is activated in cortical neurons and contributes to neurodegeneration after focal ischemia. J Neurosci 2004, 24:11404-11415. 10.1523/JNEUROSCI.3834-04.2004, 15601946.
113. Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K, Kaneko T. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 2003, 467:60-79. 10.1002/cne.10905, 14574680.
114. Wall PD, Scadding JW, Tomkiewicz MM. The production and prevention of experimental anesthesia dolorosa. Pain 1979, 6:175-182. 10.1016/0304-3959(79)90124-6, 460929.
115. Shi TJ, Liu SX, Hammarberg H, Watanabe M, Xu ZQ, Hokfelt T. Phospholipase C{beta}3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain. Proc Natl Acad Sci USA 2008, 105:20004-20008. 10.1073/pnas.0810899105, 2604939, 19066214.
116. Dal Monte M, Ristori C, Videau C, Loudes C, Martini D, Casini G, Epelbaum J, Bagnoli P. Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2010, 51:1848-1856. 10.1167/iovs.09-4472, 19959649.
117. Zhao J, Hu JY, Zhang YQ, Zhao ZQ. Involvement of spinal somatostatin receptor SST(2A) in inflammation-induced thermal hyperalgesia: ultrastructural and behavioral studies in rats. Neurochem Res 2008, 33:2099-2106. 10.1007/s11064-008-9713-x, 18452056.
118. Booth CE, Kirkup AJ, Hicks GA, Humphrey PP, Grundy D. Somatostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 2001, 121:358-369. 10.1053/gast.2001.26335, 11487545.
119. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, Tsien RY. A monomeric red fluorescent protein. Proc Natl Acad Sci USA 2002, 99:7877-7882. 10.1073/pnas.082243699, 122988, 12060735.
120. Sreenivasan VK, Stremovskiy OA, Kelf TA, Heblinski M, Goodchild AK, Connor M, Deyev SM, Zvyagin AV. Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist. Bioconjug Chem 2011, 22:1768-1775. 10.1021/bc200104u, 21823634.
121. De Martino C, Zamboni L. Silver methenamine stain for electron microscopy. J Ultrastruct Res 1967, 19:273-282. 10.1016/S0022-5320(67)80221-1, 4167848.
122. Shi TJ, Xiang Q, Zhang MD, Tortoriello G, Hammarberg H, Mulder J, Fried K, Wagner L, Josephson A, Uhlen M, Harkany T, Hökfelt T. Secretagogin is expressed in sensory CGRP neurons and in spinal cord of mouse and complements other calcium-binding proteins, with a note on rat and human. Mol Pain 2012, 8:80. 10.1186/1744-8069-8-80, 3560279, 23102406.
123. Fischer T, Doll C, Jacobs S, Kolodziej A, Stumm R, Schulz S. Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1. J Clin Endocrinol Metab 2008, 93:4519-4524. 10.1210/jc.2008-1063, 18697876.
124. Orazzo C, Pieribone VA, Ceccatelli S, Terenius L, Hökfelt T. CGRP-like immunoreactivity in A11 dopamine neurons projecting to the spinal cord and a note on CGRP-CCK cross-reactivity. Brain Res 1993, 600:39-48. 10.1016/0006-8993(93)90399-8, 8422589.
125. Brumovsky P, Stanic D, Shuster S, Herzog H, Villar M, Hokfelt T. Neuropeptide Y2 receptor protein is present in peptidergic and nonpeptidergic primary sensory neurons of the mouse. J Comp Neurol 2005, 489:328-348. 10.1002/cne.20639, 16025447.
126. Herbison AE, Simonian SX, Norris PJ, Emson PC. Relationship of neuronal nitric oxide synthase immunoreactivity to GnRH neurons in the ovariectomized and intact female rat. J Neuroendocrinol 1996, 8:73-82. 10.1111/j.1365-2826.1996.tb00688.x, 8932739.
127. Wang H, Rivero-Melian C, Robertson B, Grant G. Transganglionic transport and binding of the isolectin B4 from Griffonia simplicifolia I in rat primary sensory neurons. Neuroscience 1994, 62:539-551. 10.1016/0306-4522(94)90387-5, 7530347.
128. Lecolle K, Begard S, Caillierez R, Demeyer D, Grellier E, Loyens A, Csaba Z, Beauvillain JC, D'Halluin JC, Baroncini M, Lejeune JP, Sharif A, Prevot V, Dournaud P, Buee L, Colin M. Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors. Gene Ther 2013, 20:283-297. 10.1038/gt.2012.39, 22592599.
129. Dagerlind A, Friberg K, Bean AJ, Hökfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 1992, 98:39-49. 10.1007/BF00716936, 1429016.
130. Perez J, Rigo M, Kaupmann K, Bruns C, Yasuda K, Bell GI, Lubbert H, Hoyer D. Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization. Naunyn Schmiedebergs Arch Pharmacol 1994, 349:145-160.
131. Verge VM, Richardson PM, Wiesenfeld-Hallin Z, Hökfelt T. Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J Neurosci 1995, 15:2081-2096.